Has Lydia Sharp, MD received payments from drug or device companies?

Yes. Drug and device makers reported $941 in general payments to Lydia Sharp, MD across 45 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lydia Sharp, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lydia Sharp, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lydia Sharp, MD

Neurology · Roanoke, VANPI 1447419221

Payments from drug & device makers

$941in general payments, 2019–2025

Across 45 payments — averaging $20.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Teva Pharmaceuticals USA, Inc.$331
Biogen$258
AstraZeneca$132
AbbVie$82
Acadia Pharmaceuticals Inc$48
Argenx US, Inc.$45
plus $46 from 2 others

What the payments were for

Food & beverage$68473%
Education$25827%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Teva Pharmaceuticals USA, Inc.	28	$331
Biogen	4	$258
AstraZeneca	6	$132
AbbVie(2 entities)	2	$82
Acadia Pharmaceuticals Inc	1	$48
Argenx US, Inc.	2	$45
Genentech, Inc.	1	$31
Merz North America, Inc.	1	$15

How this compares

$941 in reported general payments places this provider in the 40th percentile of 474 neurology providers in Virginia.

See all neurology providers in Virginia →

Medicare billing

Part B allowed, 2024

$13,484

Medicare patients

Services billed

122

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Radicava OrsEdaravone	75	$1,100,585
EmflazaDeflazacort	20	$515,004
Gamunex-CImmune Globul G/Gly/Iga Avg 46	37	$271,769
NuedextaDextromethorphan Hbr/Quinidine	15	$22,597
Riluzole	48	$12,525
Pyridostigmine Bromide	49	$3,626
Pregabalin	36	$2,188
Gabapentin	32	$994
Baclofen	48	$799
Escitalopram Oxalate	32	$432
Tizanidine Hcl	28	$373
Prednisone	49	$293
Mirtazapine	14	$182
Sodium Chloride0.9 % Sodium Chloride	12	$52
FamotidineFamotidine/Pf	12	$27

Paid to pharmacies, not to this prescriber.

Other neurology in Roanoke

Aashit ShahRoanoke$102K
Michelle BetzVirginia Beach$3.3M
Daniel CohenNorfolk$2.9M
Heidi CraytonVienna$2.5M
Ramsey FalconerAlexandria$2.4M
Robert ShinCharlottesville$2.2M
Simon FishmanAlexandria$1.6M
Ingrid Loma MillerNorfolk$1.2M
Matthew BarrettHenrico$1.1M
James BickselMc Lean$1M

See the full list for Virginia →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →